Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gomez

Showing results (791-800 of 860) with videos related to

Pageof 86
Sort By:
Future Oncology (London, England)|September 16, 2024
A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancerNicholas C Turner, Mafalda Oliveira, Sacha J Howell, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00Marco Colleoni, Kathryn P Gray, Shari Gelber, et al.
The Journal of Infectious Diseases|January 15, 2008
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trialJulie E Martin, Theodore C Pierson, Sarah Hubka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2024
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy UpdateSibylle Loibl, Jacek Jassem, Amir Sonnenblick, et al.
Journal of Strength and Conditioning Research|September 5, 2014
Developmental differences between boys and girls result in sex-specific physical fitness changes from fourth to fifth gradeShawn D Flanagan, Courtenay Dunn-Lewis, Disa L Hatfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trialKomal Jhaveri, Hope S Rugo, Javier Cortés, et al.
Cancer Medicine|November 21, 2022
Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancerAlice Guan, Janet K Shim, Laura Allen, et al.
JCO Global Oncology|September 10, 2021
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin AmericaHenry L Gomez, Juan E Bargallo-Rocha, Roberto J Billinghurst, et al.
The Journal of Pediatrics|July 1, 1997
Clinical spectrum of X-linked hyper-IgM syndromeJ Levy, T Espanol-Boren, C Thomas, et al.
Pageof 86

Showing results (791-800 of 860) with videos related to

Sort By:
Pageof 86
Future Oncology (London, England)|September 16, 2024
A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancerNicholas C Turner, Mafalda Oliveira, Sacha J Howell, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00Marco Colleoni, Kathryn P Gray, Shari Gelber, et al.
The Journal of Infectious Diseases|January 15, 2008
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trialJulie E Martin, Theodore C Pierson, Sarah Hubka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2024
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy UpdateSibylle Loibl, Jacek Jassem, Amir Sonnenblick, et al.
Journal of Strength and Conditioning Research|September 5, 2014
Developmental differences between boys and girls result in sex-specific physical fitness changes from fourth to fifth gradeShawn D Flanagan, Courtenay Dunn-Lewis, Disa L Hatfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trialKomal Jhaveri, Hope S Rugo, Javier Cortés, et al.
Cancer Medicine|November 21, 2022
Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancerAlice Guan, Janet K Shim, Laura Allen, et al.
JCO Global Oncology|September 10, 2021
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin AmericaHenry L Gomez, Juan E Bargallo-Rocha, Roberto J Billinghurst, et al.
The Journal of Pediatrics|July 1, 1997
Clinical spectrum of X-linked hyper-IgM syndromeJ Levy, T Espanol-Boren, C Thomas, et al.
Pageof 86